Review





Similar Products

99
TargetMol final dmso concentration
Final Dmso Concentration, supplied by TargetMol, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/final dmso concentration/product/TargetMol
Average 99 stars, based on 1 article reviews
final dmso concentration - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

97
Selleck Chemicals final dmso concentration
Final Dmso Concentration, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/final dmso concentration/product/Selleck Chemicals
Average 97 stars, based on 1 article reviews
final dmso concentration - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

90
LC Laboratories rapamycin (300 μg/ml stock in dmso; final concentration 300 ng/ml)
Rapamycin (300 μg/Ml Stock In Dmso; Final Concentration 300 Ng/Ml), supplied by LC Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rapamycin (300 μg/ml stock in dmso; final concentration 300 ng/ml)/product/LC Laboratories
Average 90 stars, based on 1 article reviews
rapamycin (300 μg/ml stock in dmso; final concentration 300 ng/ml) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Sekisui XenoTech 1 µm uct594 (final dimethyl sulfoxide [dmso] concentration 0.25%)
1 µm Uct594 (Final Dimethyl Sulfoxide [Dmso] Concentration 0.25%), supplied by Sekisui XenoTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/1 µm uct594 (final dimethyl sulfoxide [dmso] concentration 0.25%)/product/Sekisui XenoTech
Average 90 stars, based on 1 article reviews
1 µm uct594 (final dimethyl sulfoxide [dmso] concentration 0.25%) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Millipore specific ne inhibitor iv (final concentration 100 μm, stock 20 mm in dmso)
Specific Ne Inhibitor Iv (Final Concentration 100 μm, Stock 20 Mm In Dmso), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/specific ne inhibitor iv (final concentration 100 μm, stock 20 mm in dmso)/product/Millipore
Average 90 stars, based on 1 article reviews
specific ne inhibitor iv (final concentration 100 μm, stock 20 mm in dmso) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Millipore ku5593, final concentration 10 µm from a 10 mm stock in dmso
Ku5593, Final Concentration 10 µm From A 10 Mm Stock In Dmso, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ku5593, final concentration 10 µm from a 10 mm stock in dmso/product/Millipore
Average 90 stars, based on 1 article reviews
ku5593, final concentration 10 µm from a 10 mm stock in dmso - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
LC Laboratories torin1 (5 mm stock in dmso; final concentration 5 µm)
A. Western blot of Rps6 phosphorylation in WT and cycΔ5 fus1 opto cells kept in the dark. Cells were either grown in MSL + ammonium sulfate (+ NH4), MSL + Glutamate (+Glu) or starved for 6h30 (WT) or 3h ( cycΔ5 fus1 opto ) without nitrogen (-N). Homothallic strains ( h90 ) or mix of mating types ( h+/h- ) mate in these conditions. The rps601Δ rps602 AA strain was used as control for the specificity of the phospho-specific antibody. Rps6 total levels are shown at the bottom. B. Phospho-Rps6, phospho-Psk1 and phospho-Gad8 levels in WT heterothallic ( h- ) and homothallic ( h90 ) cells starved for 6h15 and then treated with either rapamycin (300 ng/ml), <t>Torin1</t> (5 µM) or DMSO for 30 min. See for further Torin1 treatment. C. Phospho-Rps6 and phospho-Psk1 in WT and tor2 S1837E mutant treated with rapamycin or DMSO as in (B). D. Phospho-Rps6 levels in wild-type and psk1Δ mutant after 6h30 starvation. E. Time course of phospho-Rps6 and phospho-Psk1 in h-sxa2Δ cells starved in the presence of P-factor (1µg/ml) or MetOH. Starvation and P-factor addition occurred at T = 0 min.
Torin1 (5 Mm Stock In Dmso; Final Concentration 5 µm), supplied by LC Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/torin1 (5 mm stock in dmso; final concentration 5 µm)/product/LC Laboratories
Average 90 stars, based on 1 article reviews
torin1 (5 mm stock in dmso; final concentration 5 µm) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
LC Laboratories rapamycin (300 µg/ml stock in dmso; final concentration 300 ng/ml)
A. Western blot of Rps6 phosphorylation in WT and cycΔ5 fus1 opto cells kept in the dark. Cells were either grown in MSL + ammonium sulfate (+ NH4), MSL + Glutamate (+Glu) or starved for 6h30 (WT) or 3h ( cycΔ5 fus1 opto ) without nitrogen (-N). Homothallic strains ( h90 ) or mix of mating types ( h+/h- ) mate in these conditions. The rps601Δ rps602 AA strain was used as control for the specificity of the phospho-specific antibody. Rps6 total levels are shown at the bottom. B. Phospho-Rps6, phospho-Psk1 and phospho-Gad8 levels in WT heterothallic ( h- ) and homothallic ( h90 ) cells starved for 6h15 and then treated with either <t>rapamycin</t> (300 ng/ml), Torin1 (5 µM) or DMSO for 30 min. See for further Torin1 treatment. C. Phospho-Rps6 and phospho-Psk1 in WT and tor2 S1837E mutant treated with rapamycin or DMSO as in (B). D. Phospho-Rps6 levels in wild-type and psk1Δ mutant after 6h30 starvation. E. Time course of phospho-Rps6 and phospho-Psk1 in h-sxa2Δ cells starved in the presence of P-factor (1µg/ml) or MetOH. Starvation and P-factor addition occurred at T = 0 min.
Rapamycin (300 µg/Ml Stock In Dmso; Final Concentration 300 Ng/Ml), supplied by LC Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rapamycin (300 µg/ml stock in dmso; final concentration 300 ng/ml)/product/LC Laboratories
Average 90 stars, based on 1 article reviews
rapamycin (300 µg/ml stock in dmso; final concentration 300 ng/ml) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


A. Western blot of Rps6 phosphorylation in WT and cycΔ5 fus1 opto cells kept in the dark. Cells were either grown in MSL + ammonium sulfate (+ NH4), MSL + Glutamate (+Glu) or starved for 6h30 (WT) or 3h ( cycΔ5 fus1 opto ) without nitrogen (-N). Homothallic strains ( h90 ) or mix of mating types ( h+/h- ) mate in these conditions. The rps601Δ rps602 AA strain was used as control for the specificity of the phospho-specific antibody. Rps6 total levels are shown at the bottom. B. Phospho-Rps6, phospho-Psk1 and phospho-Gad8 levels in WT heterothallic ( h- ) and homothallic ( h90 ) cells starved for 6h15 and then treated with either rapamycin (300 ng/ml), Torin1 (5 µM) or DMSO for 30 min. See for further Torin1 treatment. C. Phospho-Rps6 and phospho-Psk1 in WT and tor2 S1837E mutant treated with rapamycin or DMSO as in (B). D. Phospho-Rps6 levels in wild-type and psk1Δ mutant after 6h30 starvation. E. Time course of phospho-Rps6 and phospho-Psk1 in h-sxa2Δ cells starved in the presence of P-factor (1µg/ml) or MetOH. Starvation and P-factor addition occurred at T = 0 min.

Journal: bioRxiv

Article Title: TORC1 reactivation by pheromone signaling revealed by phosphoproteomics of fission yeast sexual reproduction

doi: 10.1101/2024.06.04.597361

Figure Lengend Snippet: A. Western blot of Rps6 phosphorylation in WT and cycΔ5 fus1 opto cells kept in the dark. Cells were either grown in MSL + ammonium sulfate (+ NH4), MSL + Glutamate (+Glu) or starved for 6h30 (WT) or 3h ( cycΔ5 fus1 opto ) without nitrogen (-N). Homothallic strains ( h90 ) or mix of mating types ( h+/h- ) mate in these conditions. The rps601Δ rps602 AA strain was used as control for the specificity of the phospho-specific antibody. Rps6 total levels are shown at the bottom. B. Phospho-Rps6, phospho-Psk1 and phospho-Gad8 levels in WT heterothallic ( h- ) and homothallic ( h90 ) cells starved for 6h15 and then treated with either rapamycin (300 ng/ml), Torin1 (5 µM) or DMSO for 30 min. See for further Torin1 treatment. C. Phospho-Rps6 and phospho-Psk1 in WT and tor2 S1837E mutant treated with rapamycin or DMSO as in (B). D. Phospho-Rps6 levels in wild-type and psk1Δ mutant after 6h30 starvation. E. Time course of phospho-Rps6 and phospho-Psk1 in h-sxa2Δ cells starved in the presence of P-factor (1µg/ml) or MetOH. Starvation and P-factor addition occurred at T = 0 min.

Article Snippet: For experiment with Torin1 and Rapamycin ( and ), strains were incubated in MSL-N for 6h15 and 40 ml of cells were then treated with either 40 µl of Torin1 (5 mM stock in DMSO; final concentration 5 µM) (LC Laboratories; T-7887), 40 µl of Rapamycin (300 µg/ml stock in DMSO; final concentration 300 ng/ml) (LC Laboratories; R-5000) or 40 µl of DMSO and incubated for an additional 30 min at 30°C.

Techniques: Western Blot, Mutagenesis

A. Phospho-Rps6 and phospho-Psk1 levels in WT heterothallic ( h- ) and homothallic ( h90 ) cells starved for 6h15 and then treated with Torin1 (5 or 25 µM) or DMSO (0) for 30 min. B. CFP-Atg8 cleavage in WT and atg1Δ mutants after 4h and 8h of nitrogen starvation in MSL. The cells were pre-grown in MSL + glutamate (top) or MSL + ammonium (bottom). C. Time course of phospho-Psk1 in h-sxa2Δ atg18aΔ cells transferred to MSL + 0.75 mg/ml glutamate in the presence of P-factor (1µg/ml) or MetOH at T = 0 min.

Journal: bioRxiv

Article Title: TORC1 reactivation by pheromone signaling revealed by phosphoproteomics of fission yeast sexual reproduction

doi: 10.1101/2024.06.04.597361

Figure Lengend Snippet: A. Phospho-Rps6 and phospho-Psk1 levels in WT heterothallic ( h- ) and homothallic ( h90 ) cells starved for 6h15 and then treated with Torin1 (5 or 25 µM) or DMSO (0) for 30 min. B. CFP-Atg8 cleavage in WT and atg1Δ mutants after 4h and 8h of nitrogen starvation in MSL. The cells were pre-grown in MSL + glutamate (top) or MSL + ammonium (bottom). C. Time course of phospho-Psk1 in h-sxa2Δ atg18aΔ cells transferred to MSL + 0.75 mg/ml glutamate in the presence of P-factor (1µg/ml) or MetOH at T = 0 min.

Article Snippet: For experiment with Torin1 and Rapamycin ( and ), strains were incubated in MSL-N for 6h15 and 40 ml of cells were then treated with either 40 µl of Torin1 (5 mM stock in DMSO; final concentration 5 µM) (LC Laboratories; T-7887), 40 µl of Rapamycin (300 µg/ml stock in DMSO; final concentration 300 ng/ml) (LC Laboratories; R-5000) or 40 µl of DMSO and incubated for an additional 30 min at 30°C.

Techniques:

A. Western blot of Rps6 phosphorylation in WT and cycΔ5 fus1 opto cells kept in the dark. Cells were either grown in MSL + ammonium sulfate (+ NH4), MSL + Glutamate (+Glu) or starved for 6h30 (WT) or 3h ( cycΔ5 fus1 opto ) without nitrogen (-N). Homothallic strains ( h90 ) or mix of mating types ( h+/h- ) mate in these conditions. The rps601Δ rps602 AA strain was used as control for the specificity of the phospho-specific antibody. Rps6 total levels are shown at the bottom. B. Phospho-Rps6, phospho-Psk1 and phospho-Gad8 levels in WT heterothallic ( h- ) and homothallic ( h90 ) cells starved for 6h15 and then treated with either rapamycin (300 ng/ml), Torin1 (5 µM) or DMSO for 30 min. See for further Torin1 treatment. C. Phospho-Rps6 and phospho-Psk1 in WT and tor2 S1837E mutant treated with rapamycin or DMSO as in (B). D. Phospho-Rps6 levels in wild-type and psk1Δ mutant after 6h30 starvation. E. Time course of phospho-Rps6 and phospho-Psk1 in h-sxa2Δ cells starved in the presence of P-factor (1µg/ml) or MetOH. Starvation and P-factor addition occurred at T = 0 min.

Journal: bioRxiv

Article Title: TORC1 reactivation by pheromone signaling revealed by phosphoproteomics of fission yeast sexual reproduction

doi: 10.1101/2024.06.04.597361

Figure Lengend Snippet: A. Western blot of Rps6 phosphorylation in WT and cycΔ5 fus1 opto cells kept in the dark. Cells were either grown in MSL + ammonium sulfate (+ NH4), MSL + Glutamate (+Glu) or starved for 6h30 (WT) or 3h ( cycΔ5 fus1 opto ) without nitrogen (-N). Homothallic strains ( h90 ) or mix of mating types ( h+/h- ) mate in these conditions. The rps601Δ rps602 AA strain was used as control for the specificity of the phospho-specific antibody. Rps6 total levels are shown at the bottom. B. Phospho-Rps6, phospho-Psk1 and phospho-Gad8 levels in WT heterothallic ( h- ) and homothallic ( h90 ) cells starved for 6h15 and then treated with either rapamycin (300 ng/ml), Torin1 (5 µM) or DMSO for 30 min. See for further Torin1 treatment. C. Phospho-Rps6 and phospho-Psk1 in WT and tor2 S1837E mutant treated with rapamycin or DMSO as in (B). D. Phospho-Rps6 levels in wild-type and psk1Δ mutant after 6h30 starvation. E. Time course of phospho-Rps6 and phospho-Psk1 in h-sxa2Δ cells starved in the presence of P-factor (1µg/ml) or MetOH. Starvation and P-factor addition occurred at T = 0 min.

Article Snippet: For experiment with Torin1 and Rapamycin ( and ), strains were incubated in MSL-N for 6h15 and 40 ml of cells were then treated with either 40 µl of Torin1 (5 mM stock in DMSO; final concentration 5 µM) (LC Laboratories; T-7887), 40 µl of Rapamycin (300 µg/ml stock in DMSO; final concentration 300 ng/ml) (LC Laboratories; R-5000) or 40 µl of DMSO and incubated for an additional 30 min at 30°C.

Techniques: Western Blot, Mutagenesis